{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:47:37Z","timestamp":1791557257769,"version":"4.3.4"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00203-024-04026-z","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T04:02:37Z","timestamp":1718424157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Azole resistance in Aspergillus fumigatus- comprehensive review"],"prefix":"10.1007","volume":"206","author":[{"given":"Mthokozisi","family":"Dladla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieka","family":"Gyzenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Marias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"4026_CR1","unstructured":"(WHO), W. H. O (2022) WHO fungal priority pathogens list to guide research, development and public health action. W. H. O. (WHO), World Health Organization (WHO): 48"},{"issue":"15","key":"4026_CR2","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1517\/14656566.2015.1083976","volume":"16","author":"M Aigner","year":"2015","unstructured":"Aigner M, Lass-Florl C (2015) Treatment of drug-resistant aspergillus infection. Expert Opin Pharmacother 16(15):2267\u20132270","journal-title":"Expert Opin Pharmacother"},{"key":"4026_CR3","doi-asserted-by":"crossref","unstructured":"Alam S, Nisar M, Bano SA, Ahmad T (2022) Impact of aerial fungal spores on human health. Hazardous Environmental Micro-pollutants, Health Impacts and Allied Treatment Technologies, Springer: 219\u2013240","DOI":"10.1007\/978-3-030-96523-5_10"},{"issue":"4","key":"4026_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/bjh.12896","volume":"166","author":"L Alcazar-Fuoli","year":"2014","unstructured":"Alcazar-Fuoli L, Mellado E (2014) Current status of antifungal resistance and its impact on clinical practice. Br J Haematol 166(4):471\u2013484","journal-title":"Br J Haematol"},{"key":"4026_CR5","doi-asserted-by":"publisher","first-page":"618411","DOI":"10.3389\/fphar.2021.618411","volume":"12","author":"MS Alqahtani","year":"2021","unstructured":"Alqahtani MS, Kazi M (2021) Advances in oral drug delivery. Front Pharmacol 12:618411","journal-title":"Front Pharmacol"},{"key":"4026_CR6","doi-asserted-by":"crossref","unstructured":"Amona FM, Oladele RO, Resendiz-Sharpe A, Denning DW, Kosmidis C, Lagrou K, Zhong H, Han L (2022) Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review. Med Mycol 60(8)","DOI":"10.1093\/mmy\/myac059"},{"issue":"12","key":"4026_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/antibiotics9120877","volume":"9","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Gabald\u00f3n T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJ, Ilkit M, Lass-Fl\u00f6rl C, Perlin DS (2020) Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium. Antibiotics 9(12):877","journal-title":"Antibiotics"},{"key":"4026_CR8","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.simyco.2021.100115","volume":"100","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks JD, Rivero-Menendez O, Aljohani R, Jacobsen ID, Berman J, Osherov N, Hedayati MT, Ilkit M, Armstrong-James D, Gabaldon T, Meletiadis J, Kostrzewa M, Pan W, Lass-Florl C, Perlin DS, Hoenigl M (2021) Aspergillus Fumigatus and aspergillosis: from basics to clinics. Stud Mycol 100:100115","journal-title":"Stud Mycol"},{"key":"4026_CR10","doi-asserted-by":"crossref","unstructured":"Arendrup MC, Kahlmeter G, Guinea J, Meletiadis J, Testing S (2021) How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E. Def 11.0, exemplified by Trichophyton. Clinical Microbiology and Infection 27(1): 55\u201360","DOI":"10.1016\/j.cmi.2020.08.042"},{"key":"4026_CR11","doi-asserted-by":"crossref","unstructured":"Avkan-O\u011fuz V, \u00c7elik M, Satoglu IS, Ergon MC (2020) and A. emrah A\u00e7an Primary cutaneous Aspergillosis in immunocompetent adults: three cases and a review of the literature. Cureus 12(1)","DOI":"10.7759\/cureus.6600"},{"key":"4026_CR12","doi-asserted-by":"crossref","unstructured":"Baltussen TJH, Zoll J, Verweij PE, Melchers WJG (2020) Molecular mechanisms of Conidial Germination in Aspergillus spp. Microbiol Mol Biol Rev 84(1)","DOI":"10.1128\/MMBR.00049-19"},{"key":"4026_CR13","unstructured":"Bandres MV, Modi P, Sharma S (2023) Aspergillus Fumigatus. StatPearls. Treasure Island (FL)"},{"key":"4026_CR14","doi-asserted-by":"publisher","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L (2020) Antifungal susceptibility testing: current approaches. Clin Microbiol Rev 33(3). https:\/\/doi.org\/10.1128\/cmr.00069-00019","DOI":"10.1128\/cmr.00069-00019"},{"issue":"5","key":"4026_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/mmi.14565","volume":"114","author":"A Bermas","year":"2020","unstructured":"Bermas A, Geddes-McAlister J (2020) Combatting the evolution of antifungal resistance in Cryptococcus neoformans. Mol Microbiol 114(5):721\u2013734","journal-title":"Mol Microbiol"},{"issue":"3","key":"4026_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21448\/ijsm.714310","volume":"7","author":"KY Berna","year":"2020","unstructured":"Berna KY (2020) Imidazole antifungals: a review of their action mechanisms on cancerous cells. Int J Secondary Metabolite 7(3):139\u2013159","journal-title":"Int J Secondary Metabolite"},{"key":"4026_CR17","doi-asserted-by":"crossref","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC (2020) Candidiasis Mech Antifungal Resist Antibiot (Basel) 9(6)","DOI":"10.3390\/antibiotics9060312"},{"key":"4026_CR18","doi-asserted-by":"crossref","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW, (2017) J Fungi (Basel) 3(4)","DOI":"10.3390\/jof3040057"},{"key":"4026_CR19","doi-asserted-by":"crossref","unstructured":"Bosetti D, Neofytos D (2023) Invasive aspergillosis and the impact of azole-resistance. Curr Fungal Infect Rep 1\u201310","DOI":"10.1007\/s12281-023-00459-z"},{"key":"4026_CR20","doi-asserted-by":"crossref","unstructured":"Bouz G, Dolezal M (2021) Advances in Antifungal Drug Development: an Up-To. -Date Mini Rev Pharmaceuticals (Basel) 14(12)","DOI":"10.3390\/ph14121312"},{"issue":"8","key":"4026_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/jof8080805","volume":"8","author":"TB Burgess","year":"2022","unstructured":"Burgess TB, Condliffe AM, Elks PM (2022) A fun-guide to innate immune responses to fungal infections. J Fungi 8(8):805","journal-title":"J Fungi"},{"issue":"7","key":"4026_CR22","doi-asserted-by":"publisher","first-page":"e1009711","DOI":"10.1371\/journal.ppat.1009711","volume":"17","author":"C Burks","year":"2021","unstructured":"Burks C, Darby A, Gomez Londono L, Momany M, Brewer MT (2021) Azole-resistant aspergillus fumigatus in the environment: identifying key reservoirs and hotspots of antifungal resistance. PLoS Pathog 17(7):e1009711","journal-title":"PLoS Pathog"},{"issue":"9","key":"4026_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/00034894211052854","volume":"131","author":"AJ Burnham","year":"2022","unstructured":"Burnham AJ, Magliocca KR, Pettitt-Schieber B, Edwards TS, Marcus S, DelGaudio JM, Wise SK, Levy JM, Roland LT (2022) Intermediate Invasive Fungal Sinusitis, a distinct entity from Acute Fulminant and Chronic Invasive Fungal Sinusitis. Annals of Otology. Rhinology Laryngology 131(9):1021\u20131026","journal-title":"Rhinology Laryngology"},{"issue":"1","key":"4026_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.05088-11","volume":"56","author":"SM Camps","year":"2012","unstructured":"Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ (2012) Rapid induction of multiple resistance mechanisms in aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 56(1):10\u201316","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4026_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/jof6040321","volume":"6","author":"H Carolus","year":"2020","unstructured":"Carolus H, Pierson S, Lagrou K, Van Dijck P (2020) Amphotericin B and other Polyenes\u2014Discovery, Clinical Use, Mode of Action and Drug Resistance. J Fungi 6(4):321","journal-title":"J Fungi"},{"issue":"7","key":"4026_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","volume":"187","author":"SC Chen","year":"2007","unstructured":"Chen SC, Sorrell TC (2007) Antifungal agents. Med J Aust 187(7):404","journal-title":"Med J Aust"},{"key":"4026_CR26","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3389\/fmicb.2019.03127","volume":"10","author":"P Chen","year":"2019","unstructured":"Chen P, Liu M, Zeng Q, Zhang Z, Liu W, Sang H, Lu L (2019) Uncovering new mutations conferring Azole Resistance in the aspergillus fumigatus cyp51A gene. Front Microbiol 10:3127","journal-title":"Front Microbiol"},{"issue":"11","key":"4026_CR28","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1093\/jac\/dku259","volume":"69","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, Meis JF (2014) Multi-azole-resistant aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother 69(11):2979\u20132983","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4026_CR29","first-page":"2915","volume":"22","author":"M Cipolletti","year":"2021","unstructured":"Cipolletti M, Bartoloni S, Busonero C, Parente M, Leone S, Acconcia F (2021) A New Anti-estrogen Discovery platform identifies FDA-Approved imidazole anti-fungal drugs as Bioactive compounds against ER\u03b1. Expressing Breast Cancer Cells Int J Mol Sci 22(6):2915","journal-title":"Expressing Breast Cancer Cells Int J Mol Sci"},{"issue":"5744","key":"4026_CR31","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1126\/science.1118370","volume":"309","author":"LE Cowen","year":"2005","unstructured":"Cowen LE, Lindquist S (2005) Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309(5744):2185\u20132189","journal-title":"Science"},{"issue":"12","key":"4026_CR30","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1128\/EC.00274-06","volume":"5","author":"LE Cowen","year":"2006","unstructured":"Cowen LE, Carpenter AE, Matangkasombut O, Fink GR, Lindquist S (2006) Genetic architecture of Hsp90-dependent drug resistance. Eukaryot Cell 5(12):2184\u20132188","journal-title":"Eukaryot Cell"},{"issue":"8","key":"4026_CR33","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1073\/pnas.0813394106","volume":"106","author":"LE Cowen","year":"2009","unstructured":"Cowen LE, Singh SD, Kohler JR, Collins C, Zaas AK, Schell WA, Aziz H, Mylonakis E, Perfect JR, Whitesell L, Lindquist S (2009) Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A 106(8):2818\u20132823","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4026_CR32","doi-asserted-by":"publisher","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","volume":"5","author":"LE Cowen","year":"2014","unstructured":"Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS (2014) Mech Antifungal Drug Resist Cold Spring Harb Perspect Med 5(7):a019752","journal-title":"Mech Antifungal Drug Resist Cold Spring Harb Perspect Med"},{"key":"4026_CR34","doi-asserted-by":"crossref","unstructured":"Czyrski A, Resztak M, Swiderski P, Brylak J, Glowka FK (2021) Overv Pharmacokinetic Pharmacodynamic Interact Triazoles Pharm 13(11)","DOI":"10.3390\/pharmaceutics13111961"},{"issue":"8","key":"4026_CR35","first-page":"CD002845","volume":"8","author":"HJ Denison","year":"2020","unstructured":"Denison HJ, Worswick J, Bond CM, Grimshaw JM, Mayhew A, Gnani Ramadoss S, Robertson C, Schaafsma ME, Watson MC (2020) Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 8(8):CD002845","journal-title":"Cochrane Database Syst Rev"},{"key":"4026_CR36","doi-asserted-by":"crossref","unstructured":"Denning DW, Morgan EF (2022) Quantifying deaths from aspergillosis in HIV positive people. J Fungi (Basel) 8(11)","DOI":"10.3390\/jof8111131"},{"issue":"6","key":"4026_CR37","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","volume":"41","author":"DW Denning","year":"1997","unstructured":"Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, Warnock DW, Kelly SL (1997) Itraconazole resistance in aspergillus fumigatus. Antimicrob Agents Chemother 41(6):1364\u20131368","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"4026_CR38","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jiph.2021.11.002","volume":"14","author":"P Dhasarathan","year":"2021","unstructured":"Dhasarathan P, AlSalhi MS, Devanesan S, Subbiah J, Ranjitsingh A, Binsalah M, Alfuraydi AA (2021) Drug resistance in Candida albicans isolates and related changes in the structural domain of Mdr1 protein. J Infect Public Health 14(12):1848\u20131853","journal-title":"J Infect Public Health"},{"key":"4026_CR39","doi-asserted-by":"crossref","unstructured":"Douglas AP, Smibert OC, Bajel A, Halliday CL, Lavee O, McMullan B, Yong MK, van Hal SJ, Chen SCA and A. A. G. S. Committee (2021). Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J 51: 143\u2013176","DOI":"10.1111\/imj.15591"},{"key":"4026_CR40","doi-asserted-by":"crossref","unstructured":"Edson KK, Andrew N, Uwe G, Oliver B, Tohru G, Christine CB (2017) Diversity of Azoles Resistant Aspergillus Species Isolated from Experience and Na\u00efve Soils in Nairobi County and Naivasha Sub-County Kenya. European Scientific Journal, ESJ 13(36)","DOI":"10.19044\/esj.2017.v13n36p301"},{"issue":"14","key":"4026_CR41","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4236\/aim.2016.614103","volume":"6","author":"MA Egbuta","year":"2016","unstructured":"Egbuta MA, Mwanza M, Babalola OO (2016) A review of the ubiquity of ascomycetes filamentous fungi in relation to their economic and medical importance. Adv Microbiol 6(14):1140\u20131158","journal-title":"Adv Microbiol"},{"key":"4026_CR44","doi-asserted-by":"publisher","first-page":"275167","DOI":"10.3389\/fmicb.2017.01320","volume":"8","author":"BD Esquivel","year":"2017","unstructured":"Esquivel BD, White TC (2017) Accumulation of azole drugs in the fungal plant pathogen Magnaporthe Oryzae is the result of facilitated diffusion influx. Front Microbiol 8:275167","journal-title":"Front Microbiol"},{"issue":"6","key":"4026_CR42","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1128\/AAC.05003-14","volume":"59","author":"BD Esquivel","year":"2015","unstructured":"Esquivel BD, Smith AR, Zavrel M, White TC (2015) Azole drug import into the pathogenic fungus aspergillus fumigatus. Antimicrob Agents Chemother 59(6):3390\u20133398","journal-title":"Antimicrob Agents Chemother"},{"key":"4026_CR46","doi-asserted-by":"crossref","unstructured":"Evans TJ, Lawal A, Kosmidis C, Denning DW (2023) Chronic pulmonary aspergillosis: clinical presentation and management. Seminars in respiratory and critical Care Medicine. Thieme Medical Publishers, Inc","DOI":"10.1055\/s-0043-1776914"},{"issue":"9","key":"4026_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Bruggemann R, Garber G, Cornely OA, Gurr SJ, Harrison TS, Kuijper E, Rhodes J, Sheppard DC, Warris A, White PL, Xu J, Zwaan B, Verweij PE (2022) Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol 20(9):557\u2013571","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"4026_CR49","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/jac\/dkt075","volume":"68","author":"MG Fraczek","year":"2013","unstructured":"Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, Ramage G, Denning DW, Bowyer P (2013) The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in aspergillus fumigatus. J Antimicrob Chemother 68(7):1486\u20131496","journal-title":"J Antimicrob Chemother"},{"key":"4026_CR50","first-page":"1485","volume":"6","author":"JC Frisvad","year":"2015","unstructured":"Frisvad JC, Larsen TO (2015) Extrolites of aspergillus fumigatus and other pathogenic species in Aspergillus Section Fumigati. Front Microbiol 6:1485","journal-title":"Front Microbiol"},{"issue":"4","key":"4026_CR51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum MA, Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12(4):501\u2013517","journal-title":"Clin Microbiol Rev"},{"key":"4026_CR52","unstructured":"Giichiro O, Shinji O, Atsushi I (2018) Human Beings in Antarctica. Antarctica. K. Masaki, T. Genti and Y. Masa-yuki. Rijeka, IntechOpen: Ch. 8"},{"issue":"3","key":"4026_CR53","doi-asserted-by":"publisher","first-page":"e00276","DOI":"10.1128\/jcm.00276-21","volume":"60","author":"CG Giske","year":"2022","unstructured":"Giske CG, Turnidge J, Cant\u00f3n R, Kahlmeter G (2022) Update from the European committee on antimicrobial susceptibility testing (EUCAST). J Clin Microbiol 60(3):e00276\u2013e00221","journal-title":"J Clin Microbiol"},{"issue":"10","key":"4026_CR54","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/jctb.1590","volume":"81","author":"I Goldberg","year":"2006","unstructured":"Goldberg I, Rokem JS, Pines O (2006) Organic acids: old metabolites, new themes. J Chem Technol Biotechnol 81(10):1601\u20131611","journal-title":"J Chem Technol Biotechnol"},{"issue":"12","key":"4026_CR56","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1194\/jlr.RA120000975","volume":"61","author":"M Gomez","year":"2020","unstructured":"Gomez M, Campusano S, Gutierrez MS, Sepulveda D, Barahona S, Baeza M, Cifuentes V, Alcaino J (2020) Sterol regulatory element-binding protein Sre1 regulates carotenogenesis in the red yeast Xanthophyllomyces Dendrorhous. J Lipid Res 61(12):1658\u20131674","journal-title":"J Lipid Res"},{"issue":"3","key":"4026_CR55","doi-asserted-by":"publisher","first-page":"e0282499","DOI":"10.1371\/journal.pone.0282499","volume":"18","author":"LF Gomez Londono","year":"2023","unstructured":"Gomez Londono LF, Brewer MT (2023) Detection of azole-resistant aspergillus fumigatus in the environment from air, plant debris, compost, and soil. PLoS ONE 18(3):e0282499","journal-title":"PLoS ONE"},{"issue":"9","key":"4026_CR57","doi-asserted-by":"publisher","first-page":"e0064221","DOI":"10.1128\/AAC.00642-21","volume":"65","author":"I Gonzalez-Jimenez","year":"2021","unstructured":"Gonzalez-Jimenez I, Garcia-Rubio R, Monzon S, Lucio J, Cuesta I, Mellado E (2021) Multiresistance to Nonazole fungicides in Aspergillus Fumigatus TR(34)\/L98H azole-resistant isolates. Antimicrob Agents Chemother 65(9):e0064221","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4026_CR58","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1038\/s41467-022-32249-5","volume":"13","author":"NAR Gow","year":"2022","unstructured":"Gow NAR, Johnson C, Berman J, Coste AT, Cuomo CA, Perlin DS, Bicanic T, Harrison TS, Wiederhold N, Bromley M, Chiller T, Edgar K (2022) The importance of antimicrobial resistance in medical mycology. Nat Commun 13(1):5352","journal-title":"Nat Commun"},{"key":"4026_CR59","doi-asserted-by":"crossref","unstructured":"Hammoudi Halat D, Younes S, Mourad N, Rahal M (2022) Allylamines, Benzylamines, and fungal cell permeability: a review of mechanistic effects and usefulness against fungal pathogens. Membr (Basel) 12(12)","DOI":"10.3390\/membranes12121171"},{"key":"4026_CR60","doi-asserted-by":"crossref","unstructured":"Hoenigl M, Arastehfar A, Arendrup MC, Br\u00fcggemann R, Carvalho A, Chiller T, Chen S, Egger M, Feys S, Gangneux J-P (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev e00074\u2013e00023","DOI":"10.1128\/cmr.00074-23"},{"issue":"4","key":"4026_CR61","first-page":"1722","volume":"2","author":"CM Hossain","year":"2022","unstructured":"Hossain CM, Ryan LK, Gera M, Choudhuri S, Lyle N, Ali KA, Diamond G (2022) Antifungals drug Resist Encyclopedia 2(4):1722\u20131737","journal-title":"Antifungals drug Resist Encyclopedia"},{"issue":"5","key":"4026_CR63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","volume":"28","author":"SJ Howard","year":"2006","unstructured":"Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW (2006) Multi-azole resistance in aspergillus fumigatus. Int J Antimicrob Agents 28(5):450\u2013453","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"4026_CR62","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1507.090043","volume":"15","author":"SJ Howard","year":"2009","unstructured":"Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW (2009) Frequency and evolution of azole resistance in aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15(7):1068\u20131076","journal-title":"Emerg Infect Dis"},{"key":"4026_CR64","doi-asserted-by":"crossref","unstructured":"Hsu TH, Huang PY, Fan YC, Sun PL (2022) Azole Resistance and cyp51A Mutation of Aspergillus Fumigatus in a Tertiary Referral Hospital in Taiwan. J Fungi (Basel) 8(9)","DOI":"10.3390\/jof8090908"},{"issue":"9","key":"4026_CR66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10482-022-01762-4","volume":"115","author":"M Ijadpanahsaravi","year":"2022","unstructured":"Ijadpanahsaravi M, Teertstra WR, Wosten HAB (2022) Inter- and intra-species heterogeneity in germination of aspergillus conidia. Antonie Van Leeuwenhoek 115(9):1151\u20131164","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"24","key":"4026_CR67","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1128\/MCB.20.24.9262-9270.2000","volume":"20","author":"J Imai","year":"2000","unstructured":"Imai J, Yahara I (2000) Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin. Mol Cell Biol 20(24):9262\u20139270","journal-title":"Mol Cell Biol"},{"key":"4026_CR69","doi-asserted-by":"crossref","unstructured":"Kang SE, Sumabat LG, Melie T, Mangum B, Momany M, Brewer MT (2022) Evidence for the agricultural origin of resistance to multiple antimicrobials in aspergillus fumigatus, a fungal pathogen of humans. G3 (Bethesda) 12(2)","DOI":"10.1093\/g3journal\/jkab427"},{"key":"4026_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00253-002-1201-7","volume":"61","author":"L Karaffa","year":"2003","unstructured":"Karaffa L, Kubicek CP (2003) Aspergillus Niger citric acid accumulation: do we understand this well working black box? Appl Microbiol Biotechnol 61:189\u2013196","journal-title":"Appl Microbiol Biotechnol"},{"key":"4026_CR71","doi-asserted-by":"crossref","unstructured":"Kemoi EK, Nyerere A, Bii CC (2018) Triazole-Resistant Aspergillus fumigatus from Fungicide-Experienced Soils in Naivasha Subcounty and Nairobi County, Kenya. Int J Microbiol 2018: 7147938","DOI":"10.1155\/2018\/7147938"},{"issue":"1","key":"4026_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14756360903524304","volume":"26","author":"R Kharb","year":"2011","unstructured":"Kharb R, Sharma PC, Yar MS (2011) Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 26(1):1\u201321","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"4026_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/toxsci\/kfm012","volume":"97","author":"HM Korashy","year":"2007","unstructured":"Korashy HM, Shayeganpour A, Brocks DR, El-Kadi AO (2007) Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicol Sci 97(1):32\u201343","journal-title":"Toxicol Sci"},{"issue":"3","key":"4026_CR74","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.diagmicrobio.2012.06.030","volume":"74","author":"S Krishnan Natesan","year":"2012","unstructured":"Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH (2012) In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in aspergillus fumigatus. Diagn Microbiol Infect Dis 74(3):272\u2013277","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"4026_CR75","doi-asserted-by":"publisher","first-page":"e0120922","DOI":"10.1128\/spectrum.01209-22","volume":"10","author":"A Kuhbacher","year":"2022","unstructured":"Kuhbacher A, Peiffer M, Hortschansky P, Merschak P, Bromley MJ, Haas H, Brakhage AA, Gsaller F (2022) Azole Resistance-Associated Regulatory Motifs within the promoter of cyp51A in aspergillus fumigatus. Microbiol Spectr 10(3):e0120922","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4026_CR76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai CC, Yu WL (2021) COVID-19 associated with pulmonary aspergillosis: a literature review. J Microbiol Immunol Infect 54(1):46\u201353","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"4026_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/jop.2018.0089","volume":"35","author":"P Lakhani","year":"2019","unstructured":"Lakhani P, Patil A, Majumdar S (2019) Challenges in the polyene- and azole-based pharmacotherapy of ocular fungal infections. J Ocul Pharmacol Ther 35(1):6\u201322","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"4026_CR78","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/infdis\/jit530","volume":"209","author":"F Lamoth","year":"2014","unstructured":"Lamoth F, Juvvadi PR, Gehrke C, Asfaw YG, Steinbach WJ (2014) Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in aspergillus fumigatus. J Infect Dis 209(3):473\u2013481","journal-title":"J Infect Dis"},{"issue":"4","key":"4026_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40588-022-00181-3","volume":"9","author":"A Langfeldt","year":"2022","unstructured":"Langfeldt A, Gold JAW, Chiller T (2022) Emerging fungal infections: from the fields to the clinic, resistant aspergillus fumigatus and dermatophyte species: a one health perspective on an Urgent Public Health Problem. Curr Clin Microbiol Rep 9(4):46\u201351","journal-title":"Curr Clin Microbiol Rep"},{"issue":"16","key":"4026_CR65","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2174\/156802611796575902","volume":"11","author":"I Lepesheva","year":"2011","unstructured":"Lepesheva I, G. and, Waterman MR (2011) Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Curr Top Med Chem 11(16):2060\u20132071","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"4026_CR80","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","volume":"25","author":"PPA Lestrade","year":"2019","unstructured":"Lestrade PPA, Meis JF, Melchers WJG, Verweij PE (2019) Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management. Clin Microbiol Infect 25(7):799\u2013806","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"4026_CR81","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.femsle.2005.06.036","volume":"249","author":"CY Looi","year":"2005","unstructured":"Looi CY, D\u2019 Silva EC, Seow HF, Rosli R, Ng KP, Chong PP (2005) Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. FEMS Microbiol Lett 249(2):283\u2013289","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"4026_CR82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12281-021-00410-0","volume":"15","author":"JA L\u00f3pez-Gamboa","year":"2021","unstructured":"L\u00f3pez-Gamboa JA, Toledo-Bahena ME, Bonifaz A, Valencia-Herrera A, Camargo-S\u00e1nchez KA, Duarte-Abdala M, Mena-Cedillos CA (2021) Cutaneous aspergillosis in children and adolescents. Curr Fungal Infect Rep 15(2):41\u201348","journal-title":"Curr Fungal Infect Rep"},{"key":"4026_CR83","doi-asserted-by":"crossref","unstructured":"Lupianez CB, Martinez-Bueno M, Sanchez-Maldonado JM, Badiola J, Cunha C, Springer J, Lackner M, Segura-Catena J, Canet LM, Alcazar-Fuoli L, Lopez-Nevot MA, Fianchi L, Aguado JM, Pagano L, Lopez-Fernandez E, Alarcon-Riquelme M, Potenza L, Goncalves SM, Luppi M, Moratalla L, Solano C, Sampedro A, Gonzalez-Sierra P, Cuenca-Estrella M, Lagrou K, Maertens JA, Lass-Florl C, Einsele H, Vazquez L, Group PS, Loeffler J, Rios-Tamayo R, Carvalho A, Jurado M, Sainz J (2020) Polymorphisms within the ARNT2 and CX3CR1 genes are Associated with the risk of developing invasive aspergillosis. Infect Immun 88(4).","DOI":"10.1128\/IAI.00882-19"},{"issue":"2","key":"4026_CR84","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","volume":"47","author":"PA Mann","year":"2003","unstructured":"Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM (2003) Mutations in aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother 47(2):577\u2013581","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4026_CR85","doi-asserted-by":"publisher","first-page":"e1001126","DOI":"10.1371\/journal.ppat.1001126","volume":"6","author":"BE Mansfield","year":"2010","unstructured":"Mansfield BE, Oltean HN, Oliver BG, Hoot SJ, Leyde SE, Hedstrom L, White TC (2010) Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog 6(9):e1001126","journal-title":"PLoS Pathog"},{"key":"4026_CR87","doi-asserted-by":"crossref","unstructured":"Marek CL, Timmons SR (2019) 9 - Antimicrobials in Pediatric Dentistry. Pediatric Dentistry (Sixth Edition). A. J. Nowak, J. R. Christensen, T. R. Mabry, J. A. Townsend and M. H. Wells. Philadelphia, Elsevier: 128\u2013141.e121","DOI":"10.1016\/B978-0-323-60826-8.00009-2"},{"key":"4026_CR88","unstructured":"Marta W, Beata S-T, Wojciech F, Grzegorz N, Krzysztof Z (2019) Invasive Aspergillosis in Transplant Recipients. Surgical Recovery. S. Selim. Rijeka, IntechOpen: Ch. 6"},{"issue":"1","key":"4026_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/mol.113.085902","volume":"84","author":"N Mast","year":"2013","unstructured":"Mast N, Zheng W, Stout CD, Pikuleva IA (2013) Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1. Mol Pharmacol 84(1):86\u201394","journal-title":"Mol Pharmacol"},{"key":"4026_CR90","doi-asserted-by":"publisher","first-page":"864286","DOI":"10.3389\/fmolb.2022.864286","volume":"9","author":"MM Matin","year":"2022","unstructured":"Matin MM, Matin P, Rahman MR, Ben Hadda T, Almalki FA, Mahmud S, Ghoneim MM, Alruwaily M, Alshehri S (2022) Triazoles and their derivatives: Chemistry, Synthesis, and therapeutic applications. Front Mol Biosci 9:864286","journal-title":"Front Mol Biosci"},{"issue":"7","key":"4026_CR68","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1389557516666160118112103","volume":"16","author":"K Mazu","year":"2016","unstructured":"Mazu K, Bricker TBA, Flores-Rozas H, Ablordeppey SY (2016) The mechanistic targets of antifungal agents: an overview. Mini Rev Med Chem 16(7):555\u2013578","journal-title":"Mini Rev Med Chem"},{"issue":"11","key":"4026_CR91","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1462-5822.2010.01517.x","volume":"12","author":"A McCormick","year":"2010","unstructured":"McCormick A, Loeffler J, Ebel F (2010) Aspergillus Fumigatus: contours of an opportunistic human pathogen. Cell Microbiol 12(11):1535\u20131543","journal-title":"Cell Microbiol"},{"issue":"6","key":"4026_CR92","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1128\/AAC.01092-06","volume":"51","author":"E Mellado","year":"2007","unstructured":"Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJ, Verweij PE, Cuenca-Estrella M, Rodriguez-Tudela JL (2007) A new aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51(6):1897\u20131904","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4026_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/jinf.2000.0747","volume":"41","author":"C Moore","year":"2000","unstructured":"Moore C, Sayers N, Mosquera J, Slaven J, Denning D (2000) Antifungal drug resistance in Aspergillus. J Infect 41(3):203\u2013220","journal-title":"J Infect"},{"issue":"3","key":"4026_CR94","doi-asserted-by":"publisher","first-page":"e0111222","DOI":"10.1128\/spectrum.01112-22","volume":"10","author":"A Morogovsky","year":"2022","unstructured":"Morogovsky A, Handelman M, Abou Kandil A, Shadkchan Y, Osherov N (2022) Horizontal Gene Transfer of Triazole Resistance in Aspergillus Fumigatus. Microbiol Spectr 10(3):e0111222","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4026_CR95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"S Mousset","year":"2014","unstructured":"Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, Kruger W, Link H, Neumann S, Ostermann H, Panse J, Penack O, Rieger C, Schmidt-Hieber M, Silling G, Sudhoff T, Ullmann AJ, Wolf HH, Maschmeyer G, Bohme A (2014) Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 93(1):13\u201332","journal-title":"Ann Hematol"},{"issue":"9","key":"4026_CR96","doi-asserted-by":"publisher","first-page":"e1008819","DOI":"10.1371\/journal.ppat.1008819","volume":"16","author":"WS Moye-Rowley","year":"2020","unstructured":"Moye-Rowley WS (2020) Linkage between genes involved in azole resistance and ergosterol biosynthesis. PLoS Pathog 16(9):e1008819","journal-title":"PLoS Pathog"},{"key":"4026_CR97","doi-asserted-by":"crossref","unstructured":"Mroczy\u0144ska M, Brillowska-D\u0105browska A (2020) Rev Curr Status Echinocandins Use Antibiot (Basel) 9(5)","DOI":"10.3390\/antibiotics9050227"},{"issue":"1","key":"4026_CR98","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12879-016-1796-4","volume":"16","author":"MF Mushi","year":"2016","unstructured":"Mushi MF, Buname G, Bader O, Gross U, Mshana SE (2016) Aspergillus Fumigatus carrying TR34\/L98H resistance allele causing complicated suppurative otitis media in Tanzania: call for improved diagnosis of fungi in sub-saharan Africa. BMC Infect Dis 16(1):464","journal-title":"BMC Infect Dis"},{"issue":"12","key":"4026_CR99","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1111\/1462-2920.15274","volume":"22","author":"AV Nywening","year":"2020","unstructured":"Nywening AV, Rybak JM, Rogers PD, Fortwendel JR (2020) Mechanisms of triazole resistance in aspergillus fumigatus. Environ Microbiol 22(12):4934\u20134952","journal-title":"Environ Microbiol"},{"key":"4026_CR100","doi-asserted-by":"publisher","first-page":"103368","DOI":"10.1016\/j.fgb.2020.103368","volume":"140","author":"FFM Oliveira","year":"2020","unstructured":"Oliveira FFM, Paes HC, Peconick LDF, Fonseca FL, Marina CLF, Bocca AL, Homem-de-Mello M, Rodrigues ML, Albuquerque P, Nicola AM (2020) Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans. Fungal Genet Biol 140:103368","journal-title":"Fungal Genet Biol"},{"issue":"10","key":"4026_CR101","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.1016\/S2666-5247(21)00218-4","volume":"2","author":"A Otu","year":"2021","unstructured":"Otu A, Osaigbovo I, Orefuwa E, Ebenso B, Ojumu T (2021) Collaborative One Health approaches can mitigate increasing azole-resistant aspergillus fumigatus in Africa. Lancet Microbe 2(10):e490\u2013e491","journal-title":"Lancet Microbe"},{"issue":"3","key":"4026_CR102","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.yrtph.2009.10.005","volume":"56","author":"MW Pariza","year":"2010","unstructured":"Pariza MW, Cook M (2010) Determining the safety of enzymes used in animal feed. Regul Toxicol Pharmacol 56(3):332\u2013342","journal-title":"Regul Toxicol Pharmacol"},{"key":"4026_CR103","doi-asserted-by":"crossref","unstructured":"Park N-H, Shin K-H, Kang MK 34 - Antifungal and Antiviral Agents. Pharmacology and Therapeutics for Dentistry (Seventh Edition)., Dowd FJ, Johnson BS, Mariotti AJ (2017) Mosby: 488\u2013503","DOI":"10.1016\/B978-0-323-39307-2.00034-5"},{"issue":"10","key":"4026_CR104","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1128\/AAC.00517-08","volume":"52","author":"JE Parker","year":"2008","unstructured":"Parker JE, Merkamm M, Manning NJ, Pompon D, Kelly SL, Kelly DE (2008) Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus. Antimicrob Agents Chemother 52(10):3597\u20133603","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4026_CR105","doi-asserted-by":"publisher","first-page":"652","DOI":"10.18203\/issn.2454-5929.ijohns20201294","volume":"6","author":"BD Parmar","year":"2020","unstructured":"Parmar BD, Jha SG, Sinha V, Chaudhari NP, Dave GP (2020) A prospective analytic study of invasive fungal rhinosinsitis. Int J Otorhinolaryngol Head Neck Surg 6(4):652","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"4026_CR106","doi-asserted-by":"crossref","unstructured":"Paul S, Stamnes M, Thomas GH, Liu H, Hagiwara D, Gomi K, Filler SG, Moye-Rowley WS (2019) AtrR is an essential determinant of Azole Resistance in Aspergillus Fumigatus. mBio 10(2)","DOI":"10.1128\/mBio.02563-18"},{"issue":"1","key":"4026_CR109","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.ijantimicag.2019.09.011","volume":"55","author":"A Perez-Cantero","year":"2020","unstructured":"Perez-Cantero A, Lopez-Fernandez L, Guarro J, Capilla J (2020) Azole resistance mechanisms in aspergillus: update and recent advances. Int J Antimicrob Agents 55(1):105807","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4026_CR110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mrgentox.2008.09.011","volume":"672","author":"AA Perez-Rivera","year":"2009","unstructured":"Perez-Rivera AA, Hu T, Aardema MJ, Nash JF (2009) Evaluation of the genotoxicity of the imidazole antifungal climbazole: comparison to published results for other azole compounds. Mutat Res 672(1):27\u201339","journal-title":"Mutat Res"},{"issue":"12","key":"4026_CR111","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17(12):e383\u2013e392","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"4026_CR112","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","volume":"51","author":"LR Peyton","year":"2015","unstructured":"Peyton LR, Gallagher S, Hashemzadeh M (2015) Triazole antifungals: a review. Drugs Today (Barc) 51(12):705\u2013718","journal-title":"Drugs Today (Barc)"},{"key":"4026_CR113","doi-asserted-by":"publisher","unstructured":"Pogue JM, Jones RN, Bradley JS, Andes DR, Bhavnani SM, Drusano GL, Dudley MN, Flamm RK, Rodvold KA, Ambrose PG (2020) Polymyxin susceptibility testing and interpretive breakpoints: recommendations from the United States Committee on Antimicrobial susceptibility testing (USCAST). Antimicrob Agents Chemother 64(2). https:\/\/doi.org\/10.1128\/aac01495-01419","DOI":"10.1128\/aac01495-01419"},{"key":"4026_CR115","doi-asserted-by":"crossref","unstructured":"Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR P. E. Verweij and I. E. A. R. S. w. group (2018). Triazole resistance surveillance in aspergillus fumigatus. Med Mycol 56(suppl_1): 83\u201392","DOI":"10.1093\/mmy\/myx144"},{"key":"4026_CR114","doi-asserted-by":"crossref","unstructured":"Resendiz-Sharpe A, Dewaele K, Merckx R, Bustamante B, Vega-Gomez MC, Rolon M, Jacobs J, Verweij PE, Maertens J, Lagrou K (2021) Triazole-resistance in Environmental Aspergillus Fumigatus in Latin American and African Countries. J Fungi (Basel) 7(4)","DOI":"10.3390\/jof7040292"},{"issue":"5","key":"4026_CR116","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-022-01091-2","volume":"7","author":"J Rhodes","year":"2022","unstructured":"Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, Posso RB, Chotirmall SH, McElvaney NG, Murphy PG, Talento AF, Renwick J, Dyer PS, Szekely A, Bowyer P, Bromley MJ, Johnson EM, Lewis White P, Warris A, Barton RC, Schelenz S, Rogers TR, Armstrong-James D, Fisher MC (2022) Population genomics confirms acquisition of drug-resistant aspergillus fumigatus infection by humans from the environment. Nat Microbiol 7(5):663\u2013674","journal-title":"Nat Microbiol"},{"issue":"4","key":"4026_CR117","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/myc.13426","volume":"65","author":"M Risum","year":"2022","unstructured":"Risum M, Hare RK, Gertsen JB, Kristensen L, Rosenvinge FS, Sulim S, Abou-Chakra N, Bangsborg J, Roder BL, Marmolin ES, Astvad KMT, Pedersen M, Dzajic E, Andersen SL, Arendrup MC (2022) Azole resistance in aspergillus fumigatus. The first 2-year\u2019s data from the Danish National Surveillance Study, 2018\u20132020. Mycoses 65(4):419\u2013428","journal-title":"Mycoses"},{"key":"4026_CR118","doi-asserted-by":"crossref","unstructured":"Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M (2016) Triazole Resistance in Aspergillus spp.: a Worldwide Problem? J Fungi (Basel) 2(3)","DOI":"10.3390\/jof2030021"},{"issue":"8","key":"4026_CR119","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/jac\/dkac161","volume":"77","author":"TR Rogers","year":"2022","unstructured":"Rogers TR, Verweij PE, Castanheira M, Dannaoui E, White PL, Arendrup MC (2022) Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. J Antimicrob Chemother 77(8):2053\u20132073","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4026_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof7010001","volume":"7","author":"K Rosam","year":"2020","unstructured":"Rosam K, Monk BC, Lackner M (2020) Sterol 14\u03b1-demethylase ligand-binding pocket-mediated acquired and intrinsic azole resistance in fungal pathogens. J Fungi 7(1):1","journal-title":"J Fungi"},{"issue":"1","key":"4026_CR122","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfl051","volume":"94","author":"JT Sanderson","year":"2006","unstructured":"Sanderson JT (2006) The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 94(1):3\u201321","journal-title":"Toxicol Sci"},{"issue":"2","key":"4026_CR123","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jinf.2019.06.009","volume":"79","author":"S Schelenz","year":"2019","unstructured":"Schelenz S, Owens K, Guy R, Rautemaa-Richardson R, Manuel RJ, Richardson M, Moore C, Enoch DA, Micallef C, Howard P, Agrawal SG, Johnson EM, Muller-Pebody B (2019) National Mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: evidence of sub-optimal practice. J Infect 79(2):167\u2013173","journal-title":"J Infect"},{"key":"4026_CR124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.33393\/dti.2022.2476","volume":"16","author":"P Sen","year":"2022","unstructured":"Sen P, Vijay M, Singh S, Hameed S, Vijayaraghavan P (2022) Understanding the environmental drivers of clinical azole resistance in aspergillus species. Drug Target Insights 16:25\u201335","journal-title":"Drug Target Insights"},{"key":"4026_CR125","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","volume":"104","author":"M Shafiei","year":"2020","unstructured":"Shafiei M, Peyton L, Hashemzadeh M, Foroumadi A (2020) History of the development of antifungal azoles: a review on structures, SAR, and mechanism of action. Bioorg Chem 104:104240","journal-title":"Bioorg Chem"},{"issue":"2","key":"4026_CR126","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jgar.2015.01.005","volume":"3","author":"C Sharma","year":"2015","unstructured":"Sharma C, Hagen F, Moroti R, Meis JF, Chowdhary A (2015) Triazole-resistant aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired? J Glob Antimicrob Resist 3(2):69\u201374","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"4026_CR127","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"DJ Sheehan","year":"1999","unstructured":"Sheehan DJ, Hitchcock CA, Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12(1):40\u201379","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"4026_CR128","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12070-019-01769-w","volume":"72","author":"S Shetty","year":"2020","unstructured":"Shetty S, Chandrashekar S, Aggarwal N (2020) A study on the prevalence and clinical features of fungal sinusitis in chronic rhinosinusitis. Indian J Otolaryngol Head Neck Surg 72(1):117\u2013122","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"7","key":"4026_CR129","doi-asserted-by":"publisher","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","volume":"5","author":"SD Singh","year":"2009","unstructured":"Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE (2009) Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5(7):e1000532","journal-title":"PLoS Pathog"},{"key":"4026_CR130","doi-asserted-by":"crossref","unstructured":"Snelders E, \u2018t Huis RA (2009) Veld, A. J. Rijs, G. H. Kema, W. J. Melchers and P. E. Verweij Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 75(12): 4053\u20134057","DOI":"10.1128\/AEM.00231-09"},{"issue":"6","key":"4026_CR131","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1128\/AAC.01599-09","volume":"54","author":"E Snelders","year":"2010","unstructured":"Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ (2010) Azole resistance profile of amino acid changes in aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother 54(6):2425\u20132430","journal-title":"Antimicrob Agents Chemother"},{"key":"4026_CR132","unstructured":"Sruthi M (2021) How_do_echinocandin_antifungals_work. B. Sarfaroj Khan. PGD Health Operations"},{"key":"4026_CR133","doi-asserted-by":"publisher","first-page":"582964","DOI":"10.3389\/fped.2020.582964","volume":"8","author":"B Sunman","year":"2020","unstructured":"Sunman B, Ademhan Tural D, Ozsezen B, Emiralioglu N, Yalcin E, \u00d6z\u00e7elik U (2020) Current approach in the diagnosis and management of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Front Pead 8:582964","journal-title":"Front Pead"},{"issue":"1","key":"4026_CR134","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","volume":"37","author":"M Szymanski","year":"2022","unstructured":"Szymanski M, Chmielewska S, Czyzewska U, Malinowska M, Tylicki A (2022) Echinocandins - structure, mechanism of action and use in antifungal therapy. J Enzyme Inhib Med Chem 37(1):876\u2013894","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"4026_CR135","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2605.2007.00838.x","volume":"31","author":"C Taxvig","year":"2008","unstructured":"Taxvig C, Vinggaard AM, Hass U, Axelstad M, Metzdorff S, Nellemann C (2008) Endocrine-disrupting properties in vivo of widely used azole fungicides. Int J Androl 31(2):170\u2013177","journal-title":"Int J Androl"},{"key":"4026_CR136","doi-asserted-by":"crossref","unstructured":"Teixeira MM, Carvalho DT, Sousa E, Pinto E (2022) ew Antifungal Agents with Azole Moieties. Pharmaceuticals","DOI":"10.3390\/ph15111427"},{"issue":"2","key":"4026_CR137","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1517\/14656566.2010.517195","volume":"12","author":"H-K Tseng","year":"2011","unstructured":"Tseng H-K, Perfect JR (2011) Strategies to manage antifungal drug resistance. Expert Opin Pharmacother 12(2):241\u2013256","journal-title":"Expert Opin Pharmacother"},{"key":"4026_CR138","doi-asserted-by":"crossref","unstructured":"van der Torre MH, Novak-Frazer L, Rautemaa-Richardson R, (2020) J Fungi (Basel) 6(1)","DOI":"10.3390\/jof6010012"},{"issue":"5","key":"4026_CR139","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/jof7050367","volume":"7","author":"N Van Rhijn","year":"2021","unstructured":"Van Rhijn N, Bromley M (2021) The consequences of our changing environment on life threatening and debilitating fungal diseases in humans. J Fungi 7(5):367","journal-title":"J Fungi"},{"key":"4026_CR140","doi-asserted-by":"publisher","first-page":"100885","DOI":"10.1016\/j.drup.2022.100885","volume":"65","author":"PE Verweij","year":"2022","unstructured":"Verweij PE, Arendrup MC, Alastruey-Izquierdo A, Gold JAW, Lockhart SR, Chiller T, White PL (2022) Dual use of antifungals in medicine and agriculture: how do we help prevent resistance developing in human pathogens? Drug Resist Updat 65:100885","journal-title":"Drug Resist Updat"},{"issue":"1","key":"4026_CR141","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.simyco.2020.02.003","volume":"95","author":"CM Visagie","year":"2020","unstructured":"Visagie CM, Houbraken J (2020) Updating the taxonomy of aspergillus in South Africa. Stud Mycol 95(1):253\u2013292","journal-title":"Stud Mycol"},{"key":"4026_CR142","doi-asserted-by":"publisher","first-page":"127517","DOI":"10.1016\/j.micres.2023.127517","volume":"278","author":"M Vishwakarma","year":"2024","unstructured":"Vishwakarma M, Haider T, Soni V (2024) Update on fungal lipid biosynthesis inhibitors as antifungal agents. Microbiol Res 278:127517","journal-title":"Microbiol Res"},{"key":"4026_CR143","unstructured":"Wadhwa HKR (2023) Itraconazole. StatPearls [Internet]. Treasure Island (FL), StatPearls Publishing"},{"issue":"3","key":"4026_CR144","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1128\/AAC.02067-12","volume":"57","author":"AG Warrilow","year":"2013","unstructured":"Warrilow AG, Parker JE, Kelly DE, Kelly SL (2013) Azole affinity of sterol 14alpha-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrob Agents Chemother 57(3):1352\u20131360","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4026_CR145","first-page":"193","volume":"14","author":"K Watt","year":"2013","unstructured":"Watt K, Manzoni P, Cohen-Wolkowiez M, Rizzollo S, Boano E, Jacqz-Aigrain E, Benjamin DK (2013) Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole. Curr Drug Metab 14(2):193\u2013202","journal-title":"Curr Drug Metab"},{"issue":"2","key":"4026_CR146","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12275-015-5014-7","volume":"53","author":"X Wei","year":"2015","unstructured":"Wei X, Zhang Y, Lu L (2015) The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back. J Microbiol 53(2):91\u201399","journal-title":"J Microbiol"},{"issue":"4","key":"4026_CR147","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/QCO.0000000000000662","volume":"33","author":"NP Wiederhold","year":"2020","unstructured":"Wiederhold NP, Verweij PE (2020) Aspergillus Fumigatus and pan-azole resistance: who should be concerned? Curr Opin Infect Dis 33(4):290\u2013297","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"4026_CR148","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/AAC.49.2.518-524.2005","volume":"49","author":"Q Xiong","year":"2005","unstructured":"Xiong Q, Hassan SA, Wilson WK, Han XY, May GS, Tarrand JJ, Matsuda SP (2005) Cholesterol import by aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother 49(2):518\u2013524","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4026_CR149","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21448\/ijsm.714310","volume":"7","author":"BK Yardimci","year":"2020","unstructured":"Yardimci BK (2020) Imidazole antifungals: a review of their action mechanisms on cancerous cells. Int J Secondary Metabolite 7(3):139\u2013159","journal-title":"Int J Secondary Metabolite"},{"key":"4026_CR150","doi-asserted-by":"crossref","unstructured":"Yerbanga IW, Resendiz-Sharpe A, Bamba S, Lagrou K, Nakanabo Diallo S, Rodriguez-Villalobos H, Denis O, Montesinos I (2021) First investigative study of azole-resistant aspergillus fumigatus in the Environment in Burkina Faso. Int J Environ Res Public Health 18(5)","DOI":"10.3390\/ijerph18052250"},{"key":"4026_CR151","doi-asserted-by":"publisher","first-page":"680382","DOI":"10.3389\/fmicb.2021.680382","volume":"12","author":"R Yuan","year":"2021","unstructured":"Yuan R, Tu J, Sheng C, Chen X, Liu N (2021) Effects of Hsp90 inhibitor ganetespib on inhibition of Azole-Resistant Candida albicans. Front Microbiol 12:680382","journal-title":"Front Microbiol"},{"key":"4026_CR152","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2147\/IDR.S398858","volume":"16","author":"R Zhang","year":"2023","unstructured":"Zhang R, Zhang Y, Xu W, Han X, Zhao J (2023) Primary cutaneous aspergillosis due to aspergillus fumigatus in an Immunocompetent patient with diabetes Mellitus after Tattooing: a Case Report and Review of Literature. Infect Drug Resist 16:791\u2013797","journal-title":"Infect Drug Resist"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04026-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-024-04026-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04026-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:09:38Z","timestamp":1722931778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-024-04026-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":144,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1007\/s00203-024-04026-z","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Randomized Controlled Trial"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}